THE USE OF SUBSTITUTED TETRACYCLIC IMIDAZOLE DERIVATIVES AS ANTI-HISTAMINICS

The invention concerns the use of an H1- and/or H2-histamine receptor antagonist for the reduction of intracranial pressure (ICP), in particular for the prevention and treatment of elevated intracranial pressure and/or secondary ischaemia, in particular caused by brain injury, more in particular cau...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	FRANCISCO JAVIER FERNANDEZ-GADEA, KOENRAAD ARTHUR VAN ROSSEM, JOZEF LEO HENRI VAN REEMPTS, JOSEPH ELISABETH LEENAERTS, JOSE MANUEL BARTOLOME-NEBREDA, FRANS EDUARD JANSSENS, ANTONIO GOMEZ-SANCHEZ, PEDRO MARTINEZ-JIMENEZ, FRANK TEGTMEIER, MANUEL JESUS ALCAZAR-VACA
Format:	Patent
Sprache:	eng ; por
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!